Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,550 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model.
Tsuji T, Ozasa H, Aoki W, Aburaya S, Funazo T, Furugaki K, Yoshimura Y, Ajimizu H, Okutani R, Yasuda Y, Nomizo T, Uemasu K, Hasegawa K, Yoshida H, Yagi Y, Nagai H, Sakamori Y, Ueda M, Hirai T, Kim YH. Tsuji T, et al. Among authors: yasuda y. Mol Cancer Res. 2019 Jan;17(1):212-224. doi: 10.1158/1541-7786.MCR-18-0325. Epub 2018 Aug 31. Mol Cancer Res. 2019. PMID: 30171175
Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
Kitaoka A, Tanimura K, Yasuda Y, Nishioka K, Hirayama Y, Uemasu K, Iwashima D, Arita S, Kitai T, Hoshi S, Date E, Iizuka N, Takahashi KI. Kitaoka A, et al. Among authors: yasuda y. IDCases. 2021 Nov 16;26:e01337. doi: 10.1016/j.idcr.2021.e01337. eCollection 2021. IDCases. 2021. PMID: 34840954 Free PMC article.
The safety and efficacy of durvalumab consolidation therapy in the management of patients with stage III non-small-cell lung cancer and preexisting interstitial lung disease.
Kawanaka Y, Yasuda Y, Tanizaki J, Iwashima D, Nonagase Y, Uemasu K, Hirayama Y, Ogura M, Ozaki T, Takahashi KI. Kawanaka Y, et al. Among authors: yasuda y. Respir Investig. 2022 Sep;60(5):667-673. doi: 10.1016/j.resinv.2022.05.004. Epub 2022 Jun 18. Respir Investig. 2022. PMID: 35725721
Successful treatment with atezolizumab combination chemotherapy in a patient with high-grade fetal adenocarcinoma of the lung: A case report.
Fujimoto K, Watanabe S, Yasuda Y, Date E, Kawabata Y, Kanemura H, Takahama T, Yonesaka K, Iizuka N, Takahashi KI, Kawakami O, Ozaki T, Nakagawa K. Fujimoto K, et al. Among authors: yasuda y. Thorac Cancer. 2023 Jan;14(2):214-217. doi: 10.1111/1759-7714.14768. Epub 2022 Dec 9. Thorac Cancer. 2023. PMID: 36495048 Free PMC article.
1,550 results